Summary
Several lysosomal enzymes (β-N-acetyl-D-glucosaminidase, β-D-glucuronidase, α-D-galactosidase, β-D-galactosidase, α-D-glucosidase, β-D-glucosidase, α-L-fucosidase and α-D-mannosidase) were determined in the serum of 54 non-insulin-dependent diabetics with different degrees of metabolic control and without complications and in 18 non-insulin-dependent diabetics with complications. The serum levels of β-N-acetyl-D-glucosaminidase, β-D-glucuronidase, α-D-galactosidase, and α-D-mannosidase were significantly (p<0.01) higher in the diabetics without complications. The levels of β-N-acetyl-D-glucosaminidase and β-D-glucuronidase were inversely proportional to the degree of metabolic control, in a statistically significant manner. Moreover the levels of these enzymes decreased to normal values during a 2-month period of controlled oral hypoglycemic drug-diet therapy resulting in metabolic compensation. The presence of complications was indicated by a further increase of serum β-N-acetyl-D-glucosaminidase and β-D-glucuronidase; however the portion of lysosomal enzyme activities due to complications remained unchanged after controlled therapy aimed at compensating the metabolism. The conclusion is drawn that in non-insulin-dependent diabetics, as already shown for insulin dependent-diabetics, serum lysosomal enzymes, especially β-N-acetyl-D-glucosaminidase and β-D-glucuronidase, are good intraindividual indicators of the metabolic control of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belfiore F., Lo Vecchio L., Napoli E., Borzi V.: Increased β-N-acetylglucosaminidase activity in diabetes mellitus—Clin. Chem.20, 1229, 1974.
Burlina A. B., Goi G., Fabi A., Lombardo A., Gaburro D., Tettamanti G.: Behaviour of some lysosomal enzymes in the plasma of insulin dependent diabetic patients during artificial pancreas treatment—Clin. Biochem.20, 1987. In press.
Gabbay K. H., Hasty K., Breslow J. I., Ellison R. C., Bunn H. F., Gallop P. M.: Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus—J. clin. Endocrinol. Metabol.44, 859, 1977.
Goi G., Fabi A., Lorenzi R., Lombardo A., Tettamanti G., Burlina A. B., Pinelli L., Gaburro D.: Serum enzymes of lysosomal origin as indicators of the metabolic control in diabetes: comparison with glycated hemoglobin and albumin—Acta diabetol. lat.23, 117, 1986.
Johnson R. N., Metcalf P. A., Baker J. R.: Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control—Clin. chim. Acta127, 87, 1982.
Kohler E., Sheth K. J., Good T. A.: Plasma acidic glycohydrolases in insulin-dependent diabetes mellitus—Acta diabetol. lat.18, 243, 1981.
Lombardo A., Caimi L, Marchesini S., Goi G., Tettamanti G.: Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay—Clin. chim. Acta108, 337, 1980.
Mallia A. K., Hermanson G. T., Krohn R. I., Fujimoto E. K., Smith P. K.: Preparation and use of a boronic acid affinity support for separation and quantitation of glycosylated hemoglobins—Analyt. Letters14, 649, 1981.
Miralles J. M., Corrales J. J., Garcia-Diez L. C., Cabezas J. A., Reglero A.: N-acetyl-β-D-glucosaminidase and α-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes—Clin. chim. Acta121, 373, 1982.
National Diabetes Advisory Board: The prevention and treatment of five complications of diabetes: a guide for primary care practitioners. American Diabetes Association, 1983.
Niebes P.: Determination of enzymes and degradation products of glycosaminoglycans metabolism in the serum of healthy and varicose subjects—Clin. chim. Acta42, 399, 1972.
Perdichizzi G., Cucinotta D., Saitta A., Cavalieri A., Squadrito G.: Serum and urinary activities of β-N-acetylglucosaminidase and β-glucuronidase in diabetic patients—Acta diabetol. lat.20, 257, 1983.
Pitkänen E., Kyllästinen M., Koivula T., Hormila P.: β-N-acetylglucosaminidase and β-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy—Diabetologia18, 275, 1980.
Poon P. Y. W., Davis T. M. E., Dornan T. L., Turner R. C.: Plasma N-acetyl-β-D-glucosaminidase activities and glycaemia in diabetes mellitus—Diabetologia24, 433, 1983.
Poon P. Y. W., Dornan T. L., Ellis R. B., Turner R. C.: Increased plasma activities of N-acetyl-β, D-glucosaminidase isoenzymes in human diabetes mellitus—Clin. Endocrinol. (Oxf.)11, 625, 1979.
Saltiel A. R., Fox J. A., Sherline P., Cuatrecasas P.: Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase—Science233, 967, 1986.
Snedecor G. W., Cochran W. G.: Statistical methods. The Iowa State University Press, Ames, 1967.
Walls W. W., Collins C. A.: Phosphorylation of lysosomal membrane components as a possibly regulatory mechanism. In:Dingle J. T., Dean R. T., Sly W. (Eds): Lysosomes in biology and pathology, vol. 7. Elsevier Publ. Co., Amsterdam, 1984; pp. 119–139.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goi, G., Lombardo, A., Fabi, A. et al. Serum enzymes of lysosomal origin as indicators of the metabolic control in non-insulin-dependent diabetics. Acta diabet. lat 24, 331–340 (1987). https://doi.org/10.1007/BF02742966
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02742966